Simultaneous explantation and implantation of intrathecal pumps: a case series

Restricted access

OBJECTIVE

Intrathecal drug delivery devices (IDDDs) are a mainstay in the treatment of spasticity and refractory pain. While these devices have been shown to greatly improve the quality of life for patients, they also have a high perioperative complication and failure rate. A major complication of IDDD implantation is infection. The current standard of care in the treatment of IDDD infection necessitates that the pump be explanted and the infection treated prior to implantation of a new IDDD. This process leads to long hospital stays, interruptions in optimal medical management, and a high risk for dangerous drug withdrawals. The authors describe a technique that allows for the explantation of the infected pump and implantation of a new pump concurrently, which they have named the “Turner Switch” technique in honor of its inventor.

METHODS

The authors conducted a retrospective analysis of cases of infected IDDDs in which patients underwent simultaneous explantation of the infected pump and implantation of a new pump. Demographics and clinical data were collected.

RESULTS

Data from a total of 17 patients (11 male, 6 female) who underwent simultaneous IDDD explantation and implantation to treat infections were analyzed from a 3-year period. No patients experienced infection of the newly implanted pump or catheter. Of the 17 patients, 14 (82.4%) had baclofen pumps to treat spasticity and 3 (17.6%) had fentanyl pumps to treat chronic pain. The median hospital stay was 7 days, with 16 of 17 (94.1%) patients able to be discharged home or to a facility with a level of care similar to their preoperative care. All patients ultimately experienced complete resolution of their initial infections. Five patients (29.4%) required a return to the operating room within the next 5 months (for repair of a CSF leak in 2 cases, for treatment of infection at the old pump site in 2 cases, and for treatment of a CSF leak compounded with infection in 1 case). No patient experienced infection of the newly implanted pump or catheter.

CONCLUSIONS

IDDD infections represent a large portion of morbidity associated with these devices. The current standard of care for deep pump infections requires pump explantation and a course of antibiotics prior to reimplantation of the IDDD. The authors demonstrate the effectiveness of a procedure involving simultaneous explantation of an infected pump and implantation of a new pump on the contralateral side in the treatment of IDDD infections.

ABBREVIATIONS CP = cerebral palsy; ICU = intensive care unit; IDDD = intrathecal drug delivery device; OR = operating room; SCI = spinal cord injury.

Article Information

Correspondence Albert Lee: Indiana University–Purdue University Indianapolis, Indiana. alee@goodmancampbell.com.

INCLUDE WHEN CITING Published online April 12, 2019; DOI: 10.3171/2019.1.JNS18919.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

© AANS, except where prohibited by US copyright law.

Headings

References

  • 1

    Albright ALAwaad YMuhonen MBoydston WRGilmartin RKrach LE: Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children. J Neurosurg 101 (1 Suppl):64682004

  • 2

    Albright ALGilmartin RSwift DKrach LEIvanhoe CBMcLaughlin JF: Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 98:2912952003

  • 3

    Albright ALTurner MPattisapu JV: Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 104 (4 Suppl):2332392006

  • 4

    Armstrong RWSteinbok PCochrane DDKube SDFife SEFarrell K: Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. J Neurosurg 87:4094141997

  • 5

    Awaad YTayem HMunoz SHam SMichon AMAwaad R: Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol 18:26342003

  • 6

    Beal BR: Intrathecal drug delivery system infections (meningitis, encephalitis, pump pocket contaminants) in Anitescu MBenzon HT and Wallace MS (eds): Challenging Cases and Complication Management in Pain Medicine. Cham, Switzerland: Springer International Publishing2018 pp 219223

  • 7

    Bellinger ASiriwetchadarak RRosenquist RGreenlee JD: Prevention of intrathecal baclofen withdrawal syndrome: successful use of a temporary intrathecal catheter. Reg Anesth Pain Med 34:6006022009

  • 8

    Boviatsis EJKouyialis ATBoutsikakis IKorfias SSakas DE: Infected CNS infusion pumps. Is there a chance for treatment without removal? Acta Neurochir (Wien) 146:4634672004

  • 9

    Deer TRSmith HSCousins MDoleys DMLevy RMRathmell JP: Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician 13:E175E2132010

  • 10

    Dickey MPRice MKinnett DGLambert RDonauer SGerber MA: Infectious complications of intrathecal baclofen pump devices in a pediatric population. Pediatr Infect Dis J 32:7157222013

  • 11

    Engle MPVinh BPHarun NKoyyalagunta D: Infectious complications related to intrathecal drug delivery system and spinal cord stimulator system implantations at a comprehensive cancer pain center. Pain Physician 16:2512572013

  • 12

    Fjelstad ABHommelstad JSorteberg A: Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr 4:4874932009

  • 13

    Follett KABoortz-Marx RLDrake JMDuPen SSchneider SJTurner MS: Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections. Anesthesiology 100:158215942004

  • 14

    Ghosh DMainali GKhera JLuciano M: Complications of intrathecal baclofen pumps in children: experience from a tertiary care center. Pediatr Neurosurg 49:1381442013

  • 15

    Green LBNelson VS: Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 80:160016041999

  • 16

    Greenberg MIHendrickson RG: Baclofen withdrawal following removal of an intrathecal baclofen pump despite oral baclofen replacement. J Toxicol Clin Toxicol 41:83852003

  • 17

    Hansen CRGooch JLSuch-Neibar T: Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report. Arch Phys Med Rehabil 88:146814712007

  • 18

    Hayek SMDeer TRPope JEPanchal SJPatel VB: Intrathecal therapy for cancer and non-cancer pain. Pain Physician 14:2192482011

  • 19

    Lazorthes YSallerin-Caute BVerdie JCBastide RCarillo JP: Chronic intrathecal baclofen administration for control of severe spasticity. J Neurosurg 72:3934021990

  • 20

    Malheiro LGomes ABarbosa PSantos LSarmento A: Infectious complications of intrathecal drug administration systems for spasticity and chronic pain: 145 patients from a tertiary care center. Neuromodulation 18:4214272015

  • 21

    Ooi YCMalone JDeVera TBlyzniuk CSharan A: Successful re-implantation of intrathecal delivery system after removal secondary to infection or wound dehiscence. JHN J 5:13152010

  • 22

    Partington MD: Intrathecal baclofen therapy for cerebral palsy in Winn RH (ed): Youmans and Winn Neurological Surgery. Philadelphia: Elsevier2016 pp 19461950

  • 23

    Peerdeman SMde Groot VFeller RE: In situ treatment of an infected intrathecal baclofen pump implant with gentamicin-impregnated collagen fleece. J Neurosurg 112:130813102010

  • 24

    Rovlias APapoutsakis DPaidakakos NBlionas A: Intrathecal baclofen pump infection treated by adjunct intrareservoir teicoplanin instillation. Surg Neurol Int 8:382017 (Erratum in Surg Neurol Int 8:119 2017)

  • 25

    Sayed DMonroe FOrr WNPhadnis MKhan TWBraun E: Retrospective analysis of intrathecal drug delivery: outcomes, efficacy, and risk for cancer-related pain at a high volume academic medical center. Neuromodulation 21:6606642018

  • 26

    Vender JRHester SWaller JLRekito ALee MR: Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. J Neurosurg 104 (1 Suppl):9152006

  • 27

    Zed PJStiver HGDevonshire VJewesson PJMarra F: Continuous intrathecal pump infusion of baclofen with antibiotic drugs for treatment of pump-associated meningitis. Case report. J Neurosurg 92:3473492000

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 293 293 118
Full Text Views 37 37 10
PDF Downloads 30 30 12
EPUB Downloads 0 0 0

PubMed

Google Scholar